NovoCure Limited (NASDAQ:NVCR) Forecasted to Earn Q1 2024 Earnings of ($0.36) Per Share

NovoCure Limited (NASDAQ:NVCR – Free Report) – Equities research analysts at Wedbush increased their Q1 2024 earnings per share (EPS) estimates for shares of NovoCure in a research note issued to investors on Thursday, February 22nd. Wedbush analyst D. Nierengarten now anticipates that the medical equipment provider will post earnings per share of ($0.36) for […]

Related Keywords

United States ,Japan ,Cambridge ,Cambridgeshire ,United Kingdom ,China ,American ,Optune Lua ,Baird Financial Group Inc ,Nasdaq ,Cambridge Investment Research Advisors Inc ,American International Group Inc ,Novocure Limited ,Novocure Company Profile ,Free Report ,Get Free Report ,Investment Research Advisors ,Financial Group ,Fourth Swedish National Pension Fund ,American International Group ,International Group ,Cure Limited ,Middle East ,Novocure Daily ,Novocure ,Nasdaq Nvcr ,Nvcr ,Medical ,Earnings Estimates ,Wedbush ,